120 related articles for article (PubMed ID: 12756809)
1. Pathogenic role of a superantigen in Yersinia pseudotuberculosis infection.
Abe J; Kano H; Nogami H; Matsumoto S; Baba K; Saito H; Kohsaka T
Adv Exp Med Biol; 2003; 529():459-61. PubMed ID: 12756809
[No Abstract] [Full Text] [Related]
2. Clinical role for a superantigen in Yersinia pseudotuberculosis infection.
Abe J; Onimaru M; Matsumoto S; Noma S; Baba K; Ito Y; Kohsaka T; Takeda T
J Clin Invest; 1997 Apr; 99(8):1823-30. PubMed ID: 9109426
[TBL] [Abstract][Full Text] [Related]
3. Characterization of infections with wild and mutant Yersinia pseudotuberculosis strains in rabbit oral model.
Najdenski H; Vesselinova A; Golkocheva E; Garbom S; Wolf-Watz H
Adv Exp Med Biol; 2003; 529():117-20. PubMed ID: 12756740
[No Abstract] [Full Text] [Related]
4. Purification and gene cloning of a superantigen (YPM) produced by a patient strain of Yersinia pseudotuberculosis.
Takeda T; Yoshino K; Itoh Y; Abe J; Shimonishi Y; Kohsaka T
Contrib Microbiol Immunol; 1995; 13():331-3. PubMed ID: 8833866
[No Abstract] [Full Text] [Related]
5. Efficacy of an oral live vaccine for veterinary use against pseudotuberculosis.
Quintard B; Petit T; Ruvoen N; Carniel E; Demeure CE
Comp Immunol Microbiol Infect Dis; 2010 Dec; 33(6):e59-65. PubMed ID: 20034670
[TBL] [Abstract][Full Text] [Related]
6. Geographical heterogeneity between Far East and Europe in prevalence of ypm gene encoding the novel superantigen among Yersinia pseudotuberculosis strains.
Yoshino K; Ramamurthy T; Nair GB; Fukushima H; Ohtomo Y; Takeda N; Kaneko S; Takeda T
J Clin Microbiol; 1995 Dec; 33(12):3356-8. PubMed ID: 8586739
[TBL] [Abstract][Full Text] [Related]
7. Th1-type immune response to infection by pYV-cured phoP-phoQ null mutant of Yersinia pseudotuberculosis is defective in mouse model.
Kumar S; Balakrishna K; Agarwal GS; Merwyn S; Rai GP; Batra HV; Sardesai AA; Gowrishankar J
Antonie Van Leeuwenhoek; 2009 Jan; 95(1):91-100. PubMed ID: 18985430
[TBL] [Abstract][Full Text] [Related]
8. An extended antigenic scheme for Yersinia pseudotuberculosis.
Aleksić S; Suchan G; Bockemühl J; Aleksić V
Contrib Microbiol Immunol; 1991; 12():235-8. PubMed ID: 1718658
[No Abstract] [Full Text] [Related]
9. Characterization of a superantigen produced by Yersinia pseudotuberculosis.
Abe J; Takeda T
Prep Biochem Biotechnol; 1997; 27(2-3):173-208. PubMed ID: 9292925
[No Abstract] [Full Text] [Related]
10. [Yersinia pseudotuberculosis infection].
Takeda N
Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):496-9. PubMed ID: 10088455
[No Abstract] [Full Text] [Related]
11. The role of V antigen in mice experimentally infected with Yersinia pseudotuberculosis; histopathological study using enzyme immunoassay.
Sugiyama Y; Kaneko K; Takashima I; Hashimoto N
Nihon Juigaku Zasshi; 1986 Aug; 48(4):781-9. PubMed ID: 3531653
[No Abstract] [Full Text] [Related]
12. Lack of antibody response to invasin in humans with yersiniosis.
Fortineau N; Beretti JL; Berche P; Simonet M
Clin Diagn Lab Immunol; 1994 Mar; 1(2):235-7. PubMed ID: 7496952
[TBL] [Abstract][Full Text] [Related]
13. [Clinical findings and epidemiology of Yersinia pseudotuberculosis infection, especially concerned with Izumi fever].
Sato K
Kansenshogaku Zasshi; 1987 Jul; 61(7):746-62. PubMed ID: 3123565
[No Abstract] [Full Text] [Related]
14. Clinical manifestations of Yersinia pseudotuberculosis infection in children.
Tertti R; Vuento R; Mikkola P; Granfors K; Mäkelä AL; Toivanen A
Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):587-91. PubMed ID: 2506017
[TBL] [Abstract][Full Text] [Related]
15. A role for Toll-like receptor 4 in the host response to the lung infection of Yersinia pseudotuberculosis in mice.
Choi JA; Jeong YJ; Kim JE; Kang MJ; Kim JC; Oh SM; Lee KB; Kim DH; Kim DJ; Park JH
Comp Immunol Microbiol Infect Dis; 2016 Feb; 44():54-60. PubMed ID: 26851596
[TBL] [Abstract][Full Text] [Related]
16. [Humoral response to selected antigens of Yersinia enterocolitica and Yersinia pseudotuberculosis in the course of yersiniosis in humans. IV. Specificity of antigens].
Rastawicki W
Med Dosw Mikrobiol; 2008; 60(1):27-37. PubMed ID: 18634341
[TBL] [Abstract][Full Text] [Related]
17. [Biologically active Yersinia pseudotuberculosis biopolymers].
Dzadzieva MF
Zh Mikrobiol Epidemiol Immunobiol; 1997; (5):33-7. PubMed ID: 9432843
[No Abstract] [Full Text] [Related]
18. Role of Yersinia pseudotuberculosis outer proteins (Yops) in murine humoral immune response.
Maia JM; Monnazzi LG; Medeiros BM
Folia Microbiol (Praha); 2009; 54(3):239-45. PubMed ID: 19649742
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of 2 methods of hemagglutination tests for antibodies against strains of Yersinia enterocolitica and Yersinia pseudotuberculosis].
Rutová J
Cesk Epidemiol Mikrobiol Imunol; 1989 Jan; 38(1):40-7. PubMed ID: 2646030
[TBL] [Abstract][Full Text] [Related]
20. Role of T cells and gamma interferon in Yersinia pseudotuberculosis-derived mitogen (YPM)-induced toxicity in mice.
Kano H; Ito Y; Matsuoka K; Iwata T; Saito H; Kohsaka T; Abe J
Adv Exp Med Biol; 2003; 529():137-9. PubMed ID: 12756745
[No Abstract] [Full Text] [Related]
[Next] [New Search]
